<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39294567</PMID><DateCompleted><Year>2024</Year><Month>09</Month><Day>18</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>23</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1471-2334</ISSN><JournalIssue CitedMedium="Internet"><Volume>24</Volume><Issue>1</Issue><PubDate><Year>2024</Year><Month>Sep</Month><Day>19</Day></PubDate></JournalIssue><Title>BMC infectious diseases</Title><ISOAbbreviation>BMC Infect Dis</ISOAbbreviation></Journal><ArticleTitle>Long COVID is not the same for everyone: a hierarchical cluster analysis of Long COVID symptoms 9 and 12 months after SARS-CoV-2 test.</ArticleTitle><Pagination><StartPage>1001</StartPage><MedlinePgn>1001</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">1001</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s12879-024-09896-8</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Identifying symptom clusters in Long COVID is necessary for developing effective therapies for this diverse condition and improving the quality of life of those affected by this heterogeneous condition. In this study, we aimed to identify and compare symptom clusters at 9 and 12 months after a SARS-CoV-2 positive test and describe each cluster regarding factors at infection.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">This is a cross-sectional study with individuals randomly selected from the Portuguese National System of Epidemiological Surveillance (SINAVE) database. Individuals who had a positive RT-PCR SARS-CoV-2 test in August 2022 were contacted to participate in a telephonic interview approximately 9 and 12 months after the test. A hierarchical clustering analysis was performed, using Euclidean distance and Ward's linkage. Clustering was performed in the 35 symptoms reported 9 and 12 months after the SARS-CoV-2 positive test and characterised considering age, sex, pre-existing health conditions and symptoms at time of SARS-CoV-2 infection.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">552 individuals were included at 9 months and 458 at 12 months. The median age was 52 years (IQR: 40-64 years) and 59% were female. Hypertension and high cholesterol were the most frequently reported pre-existing health conditions. Memory loss, fatigue or weakness and joint pain were the most frequent symptoms reported 9 and 12 months after the positive test. Four clusters were identified at both times: no or minor symptoms; multi-symptoms; joint pain; and neurocognitive-related symptoms. Clusters remained similar in both times, but, within the neurocognitive cluster, memory loss and concentration issues increased in frequency at 12 months. Multi-symptoms cluster had older people, more females and more pre-existing health&#xa0;conditions at 9 months. However, at 12 months, older people and those with more pre-existing health&#xa0;conditions were in joint pain cluster.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Our results suggest that Long COVID is not the same for everyone. In our study, clusters remained similar at 9 and 12 months, except for a slight variation in the frequency of symptoms that composed each cluster. Understanding Long COVID clusters might help identify treatments for this condition. However, further validation of the observed clusters and analysis of its risk factors is needed.</AbstractText><CopyrightInformation>&#xa9; 2024. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Moniz</LastName><ForeName>Marta</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Public Health Research Centre, Comprehensive Health Research Center, NOVA National School of Public Health, CHRC, REAL, CCAL, NOVA University Lisbon, Lisbon, Portugal. martafmoniz@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ruivinho</LastName><ForeName>Carolina</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Public Health Research Centre, Comprehensive Health Research Center, NOVA National School of Public Health, CHRC, REAL, CCAL, NOVA University Lisbon, Lisbon, Portugal.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Goes</LastName><ForeName>Ana Rita</ForeName><Initials>AR</Initials><AffiliationInfo><Affiliation>Public Health Research Centre, Comprehensive Health Research Center, NOVA National School of Public Health, CHRC, REAL, CCAL, NOVA University Lisbon, Lisbon, Portugal.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Soares</LastName><ForeName>Patr&#xed;cia</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Public Health Research Centre, Comprehensive Health Research Center, NOVA National School of Public Health, CHRC, REAL, CCAL, NOVA University Lisbon, Lisbon, Portugal.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>National Institute of Health Doutor Ricardo Jorge, Lisbon, Portugal.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Leite</LastName><ForeName>Andreia</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Public Health Research Centre, Comprehensive Health Research Center, NOVA National School of Public Health, CHRC, REAL, CCAL, NOVA University Lisbon, Lisbon, Portugal.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>National Institute of Health Doutor Ricardo Jorge, Lisbon, Portugal.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>2020.09525.BD</GrantID><Agency>Funda&#xe7;&#xe3;o para a Ci&#xea;ncia e a Tecnologia</Agency><Country/></Grant><Grant><GrantID>CEECINST/00049/2021/CP2817/CT0001</GrantID><Agency>Funda&#xe7;&#xe3;o para a Ci&#xea;ncia e a Tecnologia</Agency><Country/></Grant><Grant><GrantID>UIDP/04923/2020</GrantID><Agency>Comprehensive Health Research Center</Agency><Country/></Grant><Grant><GrantID>UIDP/04923/2020</GrantID><Agency>Comprehensive Health Research Center</Agency><Country/></Grant><Grant><GrantID>UIDP/04923/2020</GrantID><Agency>Comprehensive Health Research Center</Agency><Country/></Grant><Grant><GrantID>UIDP/04923/2020</GrantID><Agency>Comprehensive Health Research Center</Agency><Country/></Grant><Grant><GrantID>UIDP/04923/2020</GrantID><Agency>Comprehensive Health Research Center</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>09</Month><Day>19</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMC Infect Dis</MedlineTA><NlmUniqueID>100968551</NlmUniqueID><ISSNLinking>1471-2334</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="ErratumIn"><RefSource>BMC Infect Dis. 2024 Oct 18;24(1):1178. doi: 10.1186/s12879-024-10086-9</RefSource><PMID Version="1">39425101</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003430" MajorTopicYN="N">Cross-Sectional Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016000" MajorTopicYN="N">Cluster Analysis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="Y">SARS-CoV-2</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="Y">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011174" MajorTopicYN="N" Type="Geographic">Portugal</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086742" MajorTopicYN="N">COVID-19 Testing</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Long COVID</Keyword><Keyword MajorTopicYN="N">Portugal</Keyword><Keyword MajorTopicYN="N">Public health</Keyword><Keyword MajorTopicYN="N">Symptoms cluster</Keyword></KeywordList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>6</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>9</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>9</Month><Day>19</Day><Hour>0</Hour><Minute>53</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>9</Month><Day>19</Day><Hour>0</Hour><Minute>52</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>9</Month><Day>18</Day><Hour>23</Hour><Minute>39</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>9</Month><Day>19</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39294567</ArticleId><ArticleId IdType="pmc">PMC11412022</ArticleId><ArticleId IdType="doi">10.1186/s12879-024-09896-8</ArticleId><ArticleId IdType="pii">10.1186/s12879-024-09896-8</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>World Health Organization. WHO Director-General&#x2019;s opening remarks at the media briefing on COVID-19: 11 March 2020. Washington D.C.; 2020. p. 4. Available from: https://www.who.int/dg/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19---11-march-2020. Cited 30 Nov 2020.</Citation></Reference><Reference><Citation>World Health Organization. A clinical case definition of post COVID-19 condition by a Delphi consensus data. Geneva; 2021.</Citation></Reference><Reference><Citation>Natarajan A, Shetty A, Delanerolle G, Zeng Y, Zhang Y, Raymont V, et al. A systematic review and meta-analysis of long COVID symptoms. Syst Rev. 2023;12(1):88.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10220332</ArticleId><ArticleId IdType="pubmed">37245047</ArticleId></ArticleIdList></Reference><Reference><Citation>Chelly S, Rouis S, Ezzi O, Ammar A, Fitouri S, Soua A, et al. Symptoms and risk factors for long COVID in Tunisian population. BMC Health Serv Res. 2023;23(1):487.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10184965</ArticleId><ArticleId IdType="pubmed">37189141</ArticleId></ArticleIdList></Reference><Reference><Citation>Feter N, Caputo EL, Leite JS, Delpino FM, da Silva LS, Vieira YP, et al. Prevalence and factors associated with long COVID in adults from Southern Brazil: Findings from the PAMPA cohort. Cad Saude Publica. 2023;39(12):e00098023.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10715571</ArticleId><ArticleId IdType="pubmed">38088735</ArticleId></ArticleIdList></Reference><Reference><Citation>Daniel CL, Fillingim S, James J, Bassler J, Lee A. Long COVID prevalence and associated characteristics among a South Alabama population. Public Health. 2023;221:135&#x2013;41.</Citation><ArticleIdList><ArticleId IdType="pubmed">37451202</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuodi P, Gorelik Y, Gausi B, Bernstine T, Edelstein M. Characterization of post-COVID syndromes by symptom cluster and time period up to 12 months post-infection: a systematic review and meta-analysis. Int J Infect Dis. 2023;134:1&#x2013;7. 10.1016/j.ijid.2023.05.003.</Citation><ArticleIdList><ArticleId IdType="pubmed">37150350</ArticleId></ArticleIdList></Reference><Reference><Citation>Kenny G, McCann K, O&#x2019;Brien C, Savinelli S, Tinago W, Yousif O, et al. Identification of distinct long COVID clinical phenotypes through cluster analysis of self-reported symptoms. Open Forum Infect Dis. 2022;9(4). Available from: 10.1093/ofid/ofac060 . Cited 22 Mar 2024.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ofid/ofac060</ArticleId><ArticleId IdType="pmc">PMC8900926</ArticleId><ArticleId IdType="pubmed">35265728</ArticleId></ArticleIdList></Reference><Reference><Citation>Nayani S, Castanares-Zapatero D, De Pauw R, Van Cauteren D, Demarest S, Drieskens S, et al. Classification of post COVID-19 condition symptoms: a longitudinal study in the Belgian population. BMJ Open. 2023;13(10):e072726 Available from: https://bmjopen.bmj.com/content/13/10/e072726. Cited 2024 Mar 26
.
</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10565235</ArticleId><ArticleId IdType="pubmed">37802617</ArticleId></ArticleIdList></Reference><Reference><Citation>Gentilotti E, G&#xf3;rska A, Tami A, Gusinow R, Mirandola M, Rodr&#xed;guez Ba&#xf1;o J, et al. Clinical phenotypes and quality of life to define post-COVID-19 syndrome: a cluster analysis of the multinational, prospective ORCHESTRA cohort. EClinicalMedicine. 2023;62:102107 https://www.thelancet.com/article/S2589537023002845/fulltext. Cited 2024 Mar 27
.
</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10466236</ArticleId><ArticleId IdType="pubmed">37654668</ArticleId></ArticleIdList></Reference><Reference><Citation>Goldhaber NH, Kohn JN, Ogan WS, Sitapati A, Longhurst CA, Wang A, et al. Deep dive into the long haul: analysis of symptom clusters and risk factors for post-acute sequelae of COVID-19 to inform clinical care. Int J Environ Res Public Health. 2022;19(24). 10.3390/ijerph192416841. Cited 26 Mar 2024.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9778884</ArticleId><ArticleId IdType="pubmed">36554723</ArticleId></ArticleIdList></Reference><Reference><Citation>Torrell G, Puente D, Jacques-Avi&#xf1;&#xf3; C, Carrasco-Ribelles LA, Viol&#xe1;n C, L&#xf3;pez-Jim&#xe9;nez T, et al. Characterisation, symptom pattern and symptom clusters from a retrospective cohort of Long COVID patients in primary care in Catalonia. BMC Infect Dis. 2024;24(1):82 Cited 2024 Mar 22.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10789045</ArticleId><ArticleId IdType="pubmed">38225587</ArticleId></ArticleIdList></Reference><Reference><Citation>van den Houdt SCM, Slurink IAL, Mertens G. Long COVID is not a uniform syndrome: Evidence from person-level symptom clusters using latent class analysis. J Infect Public Health. 2024;17(2):321&#x2013;8 Available from: https://linkinghub.elsevier.com/retrieve/pii/S1876034123004616. Cited 26 Mar 2024
.
</Citation><ArticleIdList><ArticleId IdType="pubmed">38183882</ArticleId></ArticleIdList></Reference><Reference><Citation>Ito F, Terai H, Kondo M, Takemura R, Namkoong H, Asakura T, et al. Cluster analysis of long COVID in Japan and association of its trajectory of symptoms and quality of life. BMJ Open Respir Res. 2024;11(1):e002111. 10.1136/bmjresp-2023-002111.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10895225</ArticleId><ArticleId IdType="pubmed">38395459</ArticleId></ArticleIdList></Reference><Reference><Citation>Gerritzen I, Brus IM, Spronk I, Biere-Rafi S, Polinder S, Haagsma JA. Identification of post-COVID-19 condition phenotypes, and differences in health-related quality of life and healthcare use: a cluster analysis. Epidemiol Infect. 2023;151:e123. Available from: https://www.cambridge.org/core/journals/epidemiology-and-infection/article/identification-of-postcovid19-condition-phenotypes-and-differences-in-healthrelated-quality-of-life-and-healthcare-use-a-cluster-analysis/C41527998B05928DECB7B7440604A784. Cited 2024 Mar 27.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10540165</ArticleId><ArticleId IdType="pubmed">37462040</ArticleId></ArticleIdList></Reference><Reference><Citation>Kisiel MA, Lee S, Malmquist S, Rykatkin O, Holgert S, Janols H, et al. Clustering analysis identified three long covid phenotypes and their association with general health status and working ability. J Clin Med. 2023;12(11):3617 Available from: https://www.mdpi.com/2077-0383/12/11/3617/htm. Cited 2024 Mar 26
.
</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10253616</ArticleId><ArticleId IdType="pubmed">37297812</ArticleId></ArticleIdList></Reference><Reference><Citation>Fischer A, Badier N, Zhang L, Elb&#xe9;ji A, Wilmes P, Oustric P, et al. Long COVID classification: findings from a clustering analysis in the predi-COVID cohort study. Int J Environ Res Public Health. 2022;19(23):16018 Available from: https://www.mdpi.com/1660-4601/19/23/16018/htm . Cited 27 Mar 2024
.
</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9740149</ArticleId><ArticleId IdType="pubmed">36498091</ArticleId></ArticleIdList></Reference><Reference><Citation>Kavanagh KT, Cormier LE, Pontus C, Bergman A, Webley W. Long COVID&#x2019;s impact on patients, workers, &amp; society: a review. Vol. 103, Medicine (United States). Wolters Kluwer Health; 2024. p. E37502. 10.1097/MD.0000000000037502. Cited 2024 Apr 1.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10957027</ArticleId><ArticleId IdType="pubmed">38518038</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsuchida T, Yoshimura N, Ishizuka K, Katayama K, Inoue Y, Hirose M, et al. Five cluster classifications of long COVID and their background factors: a cross-sectional study in Japan. Clin Exp Med. 2023;23(7):3663&#x2013;70. 10.1007/s10238-023-01057-6. Cited 2024 Mar 21.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10081305</ArticleId><ArticleId IdType="pubmed">37027067</ArticleId></ArticleIdList></Reference><Reference><Citation>Dinis Teixeira JP, Santos MJDS, Soares P, de Azevedo L, Barbosa P, Boas AV, et al. LOCUS (LOng Covid&#x2013;Understanding Symptoms, events and use of services in Portugal): A three-component study protocol. PLoS ONE. 2023;18(4 April):1&#x2013;12.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10132590</ArticleId><ArticleId IdType="pubmed">37099589</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization. Noncommunicable diseases global monitoring framework: Indicator definitions and specifications. Geneva: World Health Organization; 2014.</Citation></Reference><Reference><Citation>R Core Team. R: A language and environment for statistical computing. Vienna, Austria; 2022. Available from: https://www.r-project.org/.</Citation></Reference><Reference><Citation>Maechler M, Rousseeuw P, Struyf A, Hubert M, Hornik K. cluster: cluster analysis basics and extensions. R Package Version. 2023;2:1.</Citation></Reference><Reference><Citation>Reese JT, Blau H, Casiraghi E, Bergquist T, Loomba JJ, Callahan TJ, et al. Generalisable long COVID subtypes: Findings from the NIH N3C and RECOVER programmes. EBioMedicine. 2023;87:104413 Available from: https://www.thelancet.com/article/S2352396422005953/fulltext. Cited 16 May 2024
.
</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9769411</ArticleId><ArticleId IdType="pubmed">36563487</ArticleId></ArticleIdList></Reference><Reference><Citation>Blankestijn JM, Abdel-Aziz MI, Baalbaki N, Bazdar S, Beekers I, Beijers RJHCG, et al. Long COVID exhibits clinically distinct phenotypes at 3&#x2013;6 months post-SARS-CoV-2 infection: results from the P4O2 consortium. BMJ Open Respir Res. 2024;11(1):e001907. Available from: https://bmjopenrespres.bmj.com/content/11/1/e001907.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11043734</ArticleId><ArticleId IdType="pubmed">38663887</ArticleId></ArticleIdList></Reference><Reference><Citation>Bello-Chavolla OY, Ferm&#xed;n-Mart&#xed;nez CA, Ram&#xed;rez-Garc&#xed;a D, Vargas-V&#xe1;zquez A, Fern&#xe1;ndez-Chirino L, Basile-Alvarez MR, et al. Prevalence and determinants of post-acute sequelae after SARS-CoV-2 infection (Long COVID) among adults in Mexico during 2022: a retrospective analysis of nationally representative data. Lancet Reg Health - Am. 2024;30:100688. 10.1016/j.lana.2024.100688.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10847769</ArticleId><ArticleId IdType="pubmed">38327277</ArticleId></ArticleIdList></Reference><Reference><Citation>Danesh V, Arroliga AC, Bourgeois JA, Boehm LM, McNeal MJ, Widmer AJ, et al. Symptom clusters seen in adult COVID-19 recovery clinic care seekers. J Gen Intern Med. 2023;38(2):442&#x2013;9 Available from: https://link.springer.com/article/10.1007/s11606-022-07908-4 . Cited 12 Apr 2024
.
</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11606-022-07908-4</ArticleId><ArticleId IdType="pmc">PMC9663188</ArticleId><ArticleId IdType="pubmed">36376627</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong-Chew RM, Rodr&#xed;guez Cabrera EX, Rodr&#xed;guez Valdez CA, Lomelin-Gascon J, Morales-Ju&#xe1;rez L, de la Cerda MLR, et al. Symptom cluster analysis of long COVID-19 in patients discharged from the temporary COVID-19 hospital in Mexico City. Ther Adv Infect Dis. 2022;9:204993612110692. 10.1177/20499361211069264. Cited 2024 Apr 12.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8764618</ArticleId><ArticleId IdType="pubmed">35059196</ArticleId></ArticleIdList></Reference><Reference><Citation>Kenny G, McCann K, O&#x2019;Brien C, O&#x2019;Broin C, Tinago W, Yousif O, et al. Impact of vaccination and variants of concern on long COVID clinical phenotypes. BMC Infect Dis. 2023;23(1):804. 10.1186/s12879-023-08783-y. Cited 2024 Apr 12.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10655269</ArticleId><ArticleId IdType="pubmed">37974068</ArticleId></ArticleIdList></Reference><Reference><Citation>Instituto Nacional de Sa&#xfa;de Doutor Ricardo Jorge (INSA). Diversidade gen&#xe9;tica do novo coronav&#xed;rus SARS-CoV-2 (COVID-19) em Portugal. Lisboa, Portugal ; 2022. Available from: https://insaflu.insa.pt/covid19. Cited 2024 May 22.</Citation></Reference><Reference><Citation>Kabir MF, Yin KN, Jeffree MS, Ahmedy FB, Zainudin MF, Htwe O, et al. Clinical presentation of post-COVID pain and its impact on quality of life in long COVID patients: a cross-sectional household survey of SARS-CoV-2 cases in Bangladesh. BMC Infect Dis. 2024;24(1):1&#x2013;13 https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-024-09267-3. Cited 2024 May 28
.
</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12879-024-09267-3</ArticleId><ArticleId IdType="pmc">PMC10993502</ArticleId><ArticleId IdType="pubmed">38575878</ArticleId></ArticleIdList></Reference><Reference><Citation>Sunata K, Miyata J, Terai H, Matsuyama E, Watase M, Namkoong H, et al. Asthma is a risk factor for general fatigue of long COVID in Japanese nation-wide cohort study. Allergol Int. 2024;73(2):206&#x2013;13 Available from: https://linkinghub.elsevier.com/retrieve/pii/S1323893023001156 . Cited 2 Apr 2024
.
</Citation><ArticleIdList><ArticleId IdType="pubmed">37996384</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang JJ, Dong X, Liu GH, Gao YD. Risk and protective factors for COVID-19 morbidity, severity, and mortality. Clin Rev Allergy Immunol. 2022;64(1):90&#x2013;107 Available from: https://link.springer.com/article/10.1007/s12016-022-08921-5. Cited 2024 May 22
.
</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12016-022-08921-5</ArticleId><ArticleId IdType="pmc">PMC8767775</ArticleId><ArticleId IdType="pubmed">35044620</ArticleId></ArticleIdList></Reference><Reference><Citation>Subramanian A, Nirantharakumar K, Hughes S, Myles P, Williams T, Gokhale KM, et al. Symptoms and risk factors for long COVID in non-hospitalized adults. Nat Med. 2022;28(8):1706&#x2013;14 https://www.nature.com/articles/s41591-022-01909-w. Cited 2024 Apr 2
.
</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9388369</ArticleId><ArticleId IdType="pubmed">35879616</ArticleId></ArticleIdList></Reference><Reference><Citation>Alkodaymi MS, Omrani OA, Fawzy NA, Shaar BA, Almamlouk R, Riaz M, et al. Prevalence of post-acute COVID-19 syndrome symptoms at different follow-up periods: a systematic review and meta-analysis. Clin Microbiol Infect. 2022;28(5):657&#x2013;66.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8812092</ArticleId><ArticleId IdType="pubmed">35124265</ArticleId></ArticleIdList></Reference><Reference><Citation>Bamps L, Armenti JP, Bojan M, Grandbastien B, von Garnier C, Du Pasquier R, et al. Long-term consequences of COVID-19: A 1-year analysis. J Clin Med. 2023;12(7):2673.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10095027</ArticleId><ArticleId IdType="pubmed">37048757</ArticleId></ArticleIdList></Reference><Reference><Citation>Ling DQ, Gibney G, James F, Holmes NE, Chua KY. Post-COVID-19 condition symptoms 12 and 24 months after COVID-19 during the first month of the pandemic in Melbourne: a cohort study. Med J Aus. 2024;220(6):336&#x2013;8. 10.5694/mja2.52260. Cited 2024 May 22.</Citation><ArticleIdList><ArticleId IdType="pubmed">38471821</ArticleId></ArticleIdList></Reference><Reference><Citation>Vernon SD, Hartle M, Sullivan K, Bell J, Abbaszadeh S, Unutmaz D, et al. Post-exertional malaise among people with long COVID compared to myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). Work. 2023;74(4):1179&#x2013;86.</Citation><ArticleIdList><ArticleId IdType="pubmed">36911963</ArticleId></ArticleIdList></Reference><Reference><Citation>Maffitt NJ, Germann M, Baker AME, Baker MR, Baker SN, Soteropoulos DS. Recovery of neurophysiological measures in post-COVID fatigue: a 12-month longitudinal follow-up study. Sci Rep. 2024;14(1):1&#x2013;8 Available from: https://www.nature.com/articles/s41598-024-59232-y . Cited 24 May 2024
.
</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11024107</ArticleId><ArticleId IdType="pubmed">38632415</ArticleId></ArticleIdList></Reference><Reference><Citation>Matias-Guiu JA, Herrera E, Gonz&#xe1;lez-Nosti M, Krishnan K, Delgado-Alonso C, D&#xed;ez-Cirarda M, et al. Development of criteria for cognitive dysfunction in post-COVID syndrome: the IC-CoDi-COVID approach. Psychiatry Res. 2023;319: 115006.</Citation><ArticleIdList><ArticleId IdType="pubmed">36521337</ArticleId></ArticleIdList></Reference><Reference><Citation>Herrera E, del Carmen P&#xe9;rez-S&#xe1;nchez M, San Miguel-Abella R, Barrenechea A, Blanco C, Solares L et al. Cognitive impairment in young adults with post COVID-19 syndrome. 123AD; 10.1038/s41598-023-32939-0. Cited 2024 May 28.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10113715</ArticleId><ArticleId IdType="pubmed">37076533</ArticleId></ArticleIdList></Reference><Reference><Citation>Fedorowski A, Sutton R. Autonomic dysfunction and postural orthostatic tachycardia syndrome in post-acute COVID-19 syndrome. Nat Rev Cardiol. 2023;20(5):281&#x2013;2. https://www.nature.com/articles/s41569-023-00842-w.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9893964</ArticleId><ArticleId IdType="pubmed">36732397</ArticleId></ArticleIdList></Reference><Reference><Citation>Jennings S, Corrin T, Waddell L. A systematic review of the evidence on the associations and safety of COVID-19 vaccination and post COVID-19 condition. Epidemiol Infect. 2023;151:e145 Available from: https://www.cambridge.org/core/product/identifier/S0950268823001279/type/journal_article
.
</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10540166</ArticleId><ArticleId IdType="pubmed">37594232</ArticleId></ArticleIdList></Reference><Reference><Citation>Byambasuren O, Stehlik P, Clark J, Alcorn K, Glasziou P. Effect of covid-19 vaccination on long covid: systematic review. BMJ Med. 2023;2(1):e000385.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9978692</ArticleId><ArticleId IdType="pubmed">36936268</ArticleId></ArticleIdList></Reference><Reference><Citation>Sigfrid L, Drake TM, Pauley E, Jesudason EC, Olliaro P, Lim WS, et al. Long covid in adults discharged from UK hospitals after Covid-19: a prospective, multicentre cohort study using the ISARIC WHO clinical characterisation protocol. Lancet Reg Health - Eur. 2021;8:100186. 10.1016/j.lanepe.2021.100186.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8343377</ArticleId><ArticleId IdType="pubmed">34386785</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>